{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T18:51:36Z","timestamp":1793904696776,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016300","name":"Octapharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJOG Global Reports"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.xagr.2025.100501","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T19:31:49Z","timestamp":1746214309000},"page":"100501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor\/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls\/women with von Willebrand disease"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5170-5965","authenticated-orcid":false,"given":"Csongor","family":"Kiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Boda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Djambas","family":"Khayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Boban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Sidonio Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xagr.2025.100501_bib0001","unstructured":"(2024) Overview | Heavy menstrual bleeding: assessment and management | Guidance | NICE. https:\/\/www.nice.org.uk\/guidance\/ng88. Accessed 8 Jul 2024"},{"key":"10.1016\/j.xagr.2025.100501_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2023.01.017","article-title":"The relationship between heavy menstrual bleeding, iron deficiency, and iron deficiency anemia","volume":"229","author":"Munro","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.xagr.2025.100501_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12905-020-00986-8","article-title":"Barriers to seeking consultation for abnormal uterine bleeding: systematic review of qualitative research","volume":"20","author":"Henry","year":"2020","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.xagr.2025.100501_bib0004","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/hae.14765","article-title":"An expert consensus to define how higher standards of equitable care for von Willebrand disease can be achieved in the UK and Republic of Ireland","volume":"29","author":"Laffan","year":"2023","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2010.11.011","article-title":"FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age","volume":"113","author":"Munro","year":"2011","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.xagr.2025.100501_bib0006","first-page":"54","article-title":"Abnormal uterine bleeding. Best practice & research","volume":"34","author":"Whitaker","year":"2016","journal-title":"Clinical obstetrics & gynaecology"},{"key":"10.1016\/j.xagr.2025.100501_bib0007","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.3390\/jcm12175702","article-title":"Primary Hemostasis Disorders as a Cause of Heavy Menstrual Bleeding in Women of Reproductive Age","volume":"12","author":"Kontogiannis","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.xagr.2025.100501_bib0008","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJMc1616060","article-title":"Von Willebrand's Disease","volume":"376","author":"Leebeek","year":"2017","journal-title":"NEJM"},{"key":"10.1016\/j.xagr.2025.100501_bib0009","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211064064","article-title":"Prophylactic management of patients with von Willebrand disease","volume":"12","author":"Franchini","year":"2021","journal-title":"Ther Adv Hematol"},{"key":"10.1016\/j.xagr.2025.100501_bib0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/JBM.S389241","article-title":"von Willebrand disease epidemiology, burden of illness and management: A systematic review","volume":"14","author":"Du","year":"2023","journal-title":"J Blood Med"},{"key":"10.1016\/j.xagr.2025.100501_bib0011","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/17474086.2023.2166925","article-title":"The diagnosis, natural history, and management of von Willebrand disease in women in the age of guidelines","volume":"16","author":"Kalvehalli Kashinath","year":"2023","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.xagr.2025.100501_bib0012","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1111\/jth.14974","article-title":"Standardizing care to manage bleeding disorders in adolescents with heavy menses-A joint project from the ISTH pediatric\/neonatal and women's health SSCs","volume":"18","author":"Zia","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.xagr.2025.100501_bib0013","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/bloodadvances.2020003264","article-title":"ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease","volume":"5","author":"Connell","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.xagr.2025.100501_bib0014","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl 1","key":"10.1016\/j.xagr.2025.100501_bib0015","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2516.2011.02558.x","article-title":"Surveillance of female patients with inherited bleeding disorders in United States Haemophilia Treatment Centres","volume":"17","author":"Byams","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0035","unstructured":"Octapharma AG. wilate\u00ae. US prescribing information; 2023. Available at: https:\/\/wilateusa.com\/wp-content\/uploads\/2025\/02\/2024 1015_pil_18x_USA_50.49.pdf. Accessed 8 Jul 2024."},{"key":"10.1016\/j.xagr.2025.100501_bib0036","unstructured":"Octapharma AG. wilate\u00ae Summary of Product Characteristics; 2023. Available at: https:\/\/www.medicines.org.uk\/emc\/product\/2873\/smpc\/print. Accessed 27 May 2025."},{"key":"10.1016\/j.xagr.2025.100501_bib0016","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1182\/bloodadvances.2023011742","article-title":"Von Willebrand factor\/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease","volume":"8","author":"Sidonio","year":"2024","journal-title":"Blood Adv"},{"key":"10.1016\/j.xagr.2025.100501_bib0017","doi-asserted-by":"crossref","first-page":"e612","DOI":"10.1016\/S2352-3026(23)00119-9","article-title":"Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial","volume":"10","author":"Ragni","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.xagr.2025.100501_bib0018","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/hae.12005","article-title":"Efficacy and safety during formulation switch of a pasteurized VWF\/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease","volume":"19","author":"Castaman","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0019","doi-asserted-by":"crossref","DOI":"10.1177\/10760296221074348","article-title":"Clinical Efficacy and Safety of Fanhdi\u00ae, a Plasma-Derived VWF\/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study","volume":"28","author":"Jim\u00e9nez-Yuste","year":"2022","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.xagr.2025.100501_bib0020","first-page":"83","article-title":"Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin\u00ae) in paediatric patients under 6 years of age with severe von Willebrand disease","volume":"21","author":"Gouider","year":"2023","journal-title":"Blood Transfus"},{"key":"10.1016\/j.xagr.2025.100501_bib0021","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/ejh.13949","article-title":"Prophylaxis with recombinant von Willebrand factor (rVWF) in patients with type 3 von Willebrand disease (VWD): results of a post hoc analysis from a phase 3 trial","volume":"111","author":"Leebeek","year":"2023","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.xagr.2025.100501_bib0022","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/ejh.13778","article-title":"Effectiveness of long-term prophylaxis using pdFVIII\/VWF concentrate in patients with inherited von Willebrand disease","volume":"109","author":"Rugeri","year":"2022","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.xagr.2025.100501_bib0023","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MBC.0000000000000257","article-title":"Changes in bleeding patterns in von Willebrand disease after institution of long-term replacement therapy: results from the von Willebrand Disease Prophylaxis Network","volume":"26","author":"Holm","year":"2015","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.xagr.2025.100501_bib0024","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2516.2012.02916.x","article-title":"Prophylaxis in severe forms of von Willebrand's disease: results from the von Willebrand Disease Prophylaxis Network (VWD PN)","volume":"19","author":"Abshire","year":"2013","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0025","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1160\/TH10-09-0616","article-title":"Long-term secondary prophylaxis in children, adolescents and young adults with von Willebrand disease. Results of a cohort study","volume":"105","author":"Halimeh","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.xagr.2025.100501_bib0026","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MBC.0000000000000568","article-title":"Pharmacokinetics, efficacy, and safety of a plasma-derived VWF\/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study)","volume":"28","author":"Lissitchkov","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"Suppl 3","key":"10.1016\/j.xagr.2025.100501_bib0027","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/hae.14050","article-title":"von Willebrand disease: Diagnosis and treatment, treatment of women, and genomic approach to diagnosis","volume":"27","author":"Laffan","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0028","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/hae.13473","article-title":"Bleeding-related hospitalization in patients with von Willebrand disease and the impact of prophylaxis: Results from national registers in Sweden compared with normal controls and participants in the von Willebrand Disease Prophylaxis Network","volume":"24","author":"Holm","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0029","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1089\/jwh.2022.0082","article-title":"Impact of von Willebrand Disease on Women's Health Outcomes: A Matched Cohort Database Study","volume":"31","author":"Hagberg","year":"2022","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/j.xagr.2025.100501_bib0030","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1365-2516.2009.02022.x","article-title":"Complications of hysterectomy in women with von Willebrand disease","volume":"15","author":"James","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0031","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/hae.12898","article-title":"von Willebrand factor for menorrhagia: a survey and literature review","volume":"22","author":"Ragni","year":"2016","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0032","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/hae.13330","article-title":"Differences in bleeding phenotype and provider interventions in postmenarchal adolescents when compared to adult women with bleeding disorders and heavy menstrual bleeding","volume":"24","author":"Srivaths","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.xagr.2025.100501_bib0033","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/AOG.0000000000002620","article-title":"Patterns of von Willebrand Disease Screening in Girls and Adolescents With Heavy Menstrual Bleeding","volume":"131","author":"Jacobson","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.xagr.2025.100501_bib0034","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijgo.14943","article-title":"Heavy menstrual bleeding, iron deficiency, and iron deficiency anemia: Framing the issue","volume":"162","author":"Munro","year":"2023","journal-title":"Int J Gynaecol Obstet"}],"container-title":["AJOG Global Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577825000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666577825000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T21:56:47Z","timestamp":1762639007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666577825000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2666577825000620"],"URL":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100501","relation":{},"ISSN":["2666-5778"],"issn-type":[{"value":"2666-5778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of regular prophylaxis with a plasma-derived von Willebrand factor\/factor VIII concentrate with a 1:1 activity ratio in reducing heavy menstrual bleeding in girls\/women with von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"AJOG Global Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xagr.2025.100501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100501"}}